For help on how to get the results you want, see our search tips.
148 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
-
List item
Referral: Oracea
doxycycline monohydrate, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 24/04/2008, EC decision date: 22/07/2008, Last updated: 21/08/2008 -
List item
Referral: Pantoprazole Olinka (EMEA/H/A-29/1169)
pantoprazole, associated names: Pantecta, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/11/2009, EC decision date: 30/03/2010, Last updated: 08/03/2011 -
List item
Referral: Levact
bendamustine, associated names: Ribomustin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 07/07/2010, Last updated: 08/09/2011 -
List item
Referral: Adartrel
ropinirole, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 15/09/2005, EC decision date: 03/04/2006, Last updated: 21/04/2006 -
List item
Referral: Lisonorm
lisinopril, amlodipine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/07/2008, EC decision date: 12/11/2008, Last updated: 18/12/2008 -
List item
Referral: Sanohex
salbutamol, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2008, EC decision date: 12/03/2009, Last updated: 30/03/2009 -
List item
Referral: Lansoprazol HEXAL 15 mg and 30 mg
Lansoprazole, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/06/2005, EC decision date: 15/09/2005, Last updated: 15/09/2005 -
List item
Referral: Mifepristone Linepharma
mifepristone, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 21/06/2012, EC decision date: 11/09/2012, Last updated: 03/01/2013 -
List item
Referral: Actilyse
Alteplase, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 27/06/2002, EC decision date: 30/09/2002, Last updated: 25/01/2006 -
List item
Referral: Octegra
moxifloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/03/2009, EC decision date: 02/10/2009, Last updated: 25/06/2009 -
List item
Referral: Ethirfin
morphine sulphate, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/09/2010, EC decision date: 20/12/2010, Last updated: 29/04/2011 -
List item
Referral: Myderison
tolperisone hydrochloride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 22/10/2009, EC decision date: 06/08/2010, Last updated: 16/06/2011 -
List item
Referral: Glimepirida Parke-Davis
glimepiride, associated names: Glimepiride Pfizer, Glimepirid Pfizer, Glimepiride tablets 2 mg, Glimepiride tablets 3 mg, Glimepiride tablets 4 mg, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/07/2012, EC decision date: 19/11/2012, Last updated: 06/12/2012 -
List item
Referral: Amaryl
glimepiride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 17/04/1996, EC decision date: 29/08/1996, Last updated: 03/08/1998 -
List item
Referral: Pantoprazole Bluefish
pantoprazole, associated names: Pantecta, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/11/2009, EC decision date: 30/03/2010, Last updated: 09/03/2011 -
List item
Referral: Corlentor and Procoralan
ivabradine, associated names: Corlentor and Procoralan, Article 20 procedures
Status: European Commission final decision, opinion/position date: 20/11/2014, EC decision date: 15/01/2015, Last updated: 16/02/2015 -
List item
Referral: Valebo and associated names
alendronic acid, alfacalcidol, associated names: Tevabone, Teboneva, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2013, EC decision date: 10/03/2014, Last updated: 31/03/2014 -
List item
Referral: Merisone and associated names
tolperisone, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/04/2015, EC decision date: 25/06/2015, Last updated: 28/07/2015 -
List item
Referral: Avalox
moxifloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/06/2009, EC decision date: 02/10/2009, Last updated: 19/11/2013 -
List item
Referral: Flutiform
fluticasone propionate, formoterol fumarate, associated names: Iffeza, Flofera, Flutiformo, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 28/06/2012, Last updated: 25/10/2012 -
List item
Referral: Tetrazepam-containing medicines
tetrazepam, associated names: Myolastan and generics, Article 107i procedures
Status: European Commission final decision, opinion/position date: 24/04/2013, EC decision date: 29/05/2013, Last updated: 18/07/2013 -
List item
Referral: Activelle
estradiol, norethisterone acetate, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 26/06/2008, EC decision date: 11/09/2008, Last updated: 25/09/2008 -
List item
Referral: Cyproterone- and ethinylestradiol-containing medicines
cyproterone, ethinyl estradiol, associated names: Acnemine, Acneson, Chloe, Clairette, Cyprest, Cyprodiol, Diane 35, Dianette, Feminil, Minerva, Zyrona, Article 107i procedures
Status: European Commission final decision, opinion/position date: 29/05/2013, EC decision date: 25/07/2013, Last updated: 05/08/2013 -
List item
Referral: Numeta G13%E and Numeta G16%E emulsion for infusion
Article 107i procedures
Status: CMDh final position, opinion/position date: 18/09/2013, Last updated: 27/09/2013 -
List item
Referral: Doxagamma 4mg
Doxazosin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 28/06/2006, EC decision date: 11/10/2006, Last updated: 11/10/2006